Andrea Fanjul

2.1k total citations
27 papers, 1.4k citations indexed

About

Andrea Fanjul is a scholar working on Molecular Biology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Andrea Fanjul has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Genetics and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Andrea Fanjul's work include Estrogen and related hormone effects (13 papers), Retinoids in leukemia and cellular processes (10 papers) and Antioxidant Activity and Oxidative Stress (6 papers). Andrea Fanjul is often cited by papers focused on Estrogen and related hormone effects (13 papers), Retinoids in leukemia and cellular processes (10 papers) and Antioxidant Activity and Oxidative Stress (6 papers). Andrea Fanjul collaborates with scholars based in United States, Japan and Argentina. Andrea Fanjul's co-authors include Magnus Pfahl, Marcia I. Dawson, James F. Cameron, Ling Jong, Xian Lu, Jürgen M. Lehmann, Gerhart Graupner, Eli Harlev, Peter D. Hobbs and Domenico Delia and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Andrea Fanjul

27 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Fanjul United States 16 1.1k 600 295 224 154 27 1.4k
Peter R. Reczek United States 20 999 0.9× 571 1.0× 212 0.7× 146 0.7× 53 0.3× 31 1.3k
S K Karathanasis United States 13 1.2k 1.1× 566 0.9× 82 0.3× 115 0.5× 465 3.0× 14 1.8k
Alexander Yemelyanov United States 17 389 0.3× 190 0.3× 95 0.3× 146 0.7× 98 0.6× 23 906
Rosemary E. Hall Australia 17 701 0.6× 843 1.4× 58 0.2× 67 0.3× 207 1.3× 18 1.5k
Giuseppe Bunone Italy 14 1.1k 1.0× 855 1.4× 27 0.1× 119 0.5× 334 2.2× 15 1.8k
Jacqueline M. Bentel Australia 22 942 0.8× 747 1.2× 49 0.2× 75 0.3× 359 2.3× 53 1.9k
Chibo Hong United States 20 1.8k 1.6× 316 0.5× 26 0.1× 72 0.3× 62 0.4× 33 2.4k
Aruna Basu United States 19 1.2k 1.1× 112 0.2× 52 0.2× 138 0.6× 43 0.3× 23 1.9k
Elliott Klein United States 14 475 0.4× 270 0.5× 74 0.3× 129 0.6× 49 0.3× 23 683

Countries citing papers authored by Andrea Fanjul

Since Specialization
Citations

This map shows the geographic impact of Andrea Fanjul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Fanjul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Fanjul more than expected).

Fields of papers citing papers by Andrea Fanjul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Fanjul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Fanjul. The network helps show where Andrea Fanjul may publish in the future.

Co-authorship network of co-authors of Andrea Fanjul

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Fanjul. A scholar is included among the top collaborators of Andrea Fanjul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Fanjul. Andrea Fanjul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Huey-Jing, James Bilakovics, Andrea Fanjul, et al.. (2019). MetAP2 inhibition increases energy expenditure through direct action on brown adipocytes. Journal of Biological Chemistry. 294(24). 9567–9575. 7 indexed citations
2.
Huang, Huey-Jing, Deepika Balakrishna, James Bilakovics, et al.. (2019). Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors. Journal of Pharmacology and Experimental Therapeutics. 371(2). 299–308. 6 indexed citations
3.
Riopel, Matthew, Jong Bae Seo, Gautam Bandyopadhyay, et al.. (2018). Chronic fractalkine administration improves glucose tolerance and pancreatic endocrine function. Journal of Clinical Investigation. 128(4). 1458–1470. 30 indexed citations
4.
Riopel, Matthew, Melanie Vassallo, Erik Ehinger, et al.. (2018). CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO mice. Molecular Metabolism. 20. 89–101. 25 indexed citations
5.
Gibson, Tony, et al.. (2017). Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy. Bioorganic & Medicinal Chemistry Letters. 27(8). 1709–1713. 15 indexed citations
6.
Kuruma, Hidetoshi, Hiroaki Matsumoto, Masaki Shiota, et al.. (2013). A Novel Antiandrogen, Compound 30, Suppresses Castration-Resistant and MDV3100-Resistant Prostate Cancer Growth In Vitro and In Vivo. Molecular Cancer Therapeutics. 12(5). 567–576. 86 indexed citations
7.
Zhu, Zhou, Wenyue Hu, Heather Estrella, et al.. (2012). Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding. BMC Genomics. 13(1). 355–355. 7 indexed citations
8.
Guo, Chuangxing, Mason Pairish, Angelica Linton, et al.. (2012). Design of oxobenzimidazoles and oxindoles as novel androgen receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 22(7). 2572–2578. 20 indexed citations
9.
Guo, Chuangxing, Susan E. Kephart, Martha A. Ornelas, et al.. (2011). Discovery of 3-aryloxy-lactam analogs as potent androgen receptor full antagonists for treating castration resistant prostate cancer. Bioorganic & Medicinal Chemistry Letters. 22(2). 1230–1236. 11 indexed citations
10.
Siu, Michael, Theodore Johnson, Yong Wang, et al.. (2009). N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11β-hydroxysteroid dehydrogenase type 1: Discovery of PF-915275. Bioorganic & Medicinal Chemistry Letters. 19(13). 3493–3497. 35 indexed citations
11.
12.
Lu, Xianping, Andrea Fanjul, Nathalie Picard, Braham Shroot, & Magnus Pfahl. (1999). A selective retinoid with high activity against an androgen-resistant prostate cancer cell type. International Journal of Cancer. 80(2). 272–278. 34 indexed citations
13.
Lu, Xianping, Andrea Fanjul, Nathalie Picard, Braham Shroot, & Magnus Pfahl. (1999). A selective retinoid with high activity against an androgen‐resistant prostate cancer cell type. International Journal of Cancer. 80(2). 272–278. 2 indexed citations
14.
Lu, Xianping, Andrea Fanjul, Nathalie Picard, et al.. (1997). Novel retinoid-related molecules as apoptosis inducers and effectve inhibitors of human lung cancer cells in vivo. Nature Medicine. 3(6). 686–690. 71 indexed citations
15.
Fanjul, Andrea, et al.. (1996). 4-Hydroxyphenyl Retinamide Is a Highly Selective Activator of Retinoid Receptors. Journal of Biological Chemistry. 271(37). 22441–22446. 156 indexed citations
16.
Fanjul, Andrea, Hakim Bouterfa, Marcia I. Dawson, & Magnus Pfahl. (1996). Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons.. PubMed. 56(7). 1571–7. 40 indexed citations
17.
Fanjul, Andrea, et al.. (1996). 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. Journal of Biological Chemistry. 271(52). 33705–33705. 13 indexed citations
18.
Fanjul, Andrea, Marcia I. Dawson, Peter D. Hobbs, et al.. (1994). A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature. 372(6501). 107–111. 268 indexed citations
19.
Pfahl, Magnus, Rainer Apfel, Igor Bendik, et al.. (1994). Nuclear Retinoid Receptors and Their Mechanism of Action. Vitamins and hormones. 49. 327–382. 57 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter R. Reczek Breakdown of academic impact, for papers by S K Karathanasis Breakdown of academic impact, for papers by Alexander Yemelyanov Breakdown of academic impact, for papers by Rosemary E. Hall Breakdown of academic impact, for papers by Giuseppe Bunone Breakdown of academic impact, for papers by Jacqueline M. Bentel Breakdown of academic impact, for papers by Chibo Hong Breakdown of academic impact, for papers by Aruna Basu Breakdown of academic impact, for papers by Elliott Klein
Rankless by CCL
2026